2026-06-14T03:46:18Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/154912025-03-26T11:32:40Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608col_20.500.12105_19609

00925njm 22002777a 4500 dc Melidou, Angeliki author Broberg, Eeva K author European region influenza surveillance network author Pozo Sanchez, Francisco author Casas Flecha, Inmaculada author Larrauri, Amparo author Oliva Dominguez, Jesus Angel author Delgado-Sanz, Concepcion author 2017-09-05 During the European 2016/17 influenza season, A(H3N2) viruses have predominated and the majority clustered in genetic subclade 3C.2a1. Genetic analyses showed that circulating viruses have undergone considerable genetic diversification of the haemagglutinin gene from the current vaccine virus A/Hong Kong/4801/2014 (clade 3C.2a), but the antigenic data that is limited by the challenges with the antigenic characterisation of currently circulating A(H3N2) viruses, showed no clear evidence of antigenic change. The recommended A(H3N2) vaccine component for the northern hemisphere 2017/18 influenza season remained unchanged. However, early and mid-season vaccine effectiveness (VE) estimates were suggestive of reduced VE against A(H3N2) viruses. Vaccine. 2017 Sep 5;35(37):4828-4835. 10.1016/j.vaccine.2017.07.057 1873-2518 Vaccine 28780977 http://hdl.handle.net/20.500.12105/15491 A(H3N2) Amino acid substitution Emergence Europe Influenza virus Season Surveillance Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18